Interleukin-10 gene promoter polymorphism in patients with schizophrenia in a region of East Turkey

References

• American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorder (DSM-IV)4th ed. Washington, DC, American Psychiatric Press.
   Google Scholar
• Cazzullo CL, Trabattoni D, Saresella M, Annoni G, Arosio B, Clerici M. Research on psychoimmunology. World J Biol Psychiatry 2003; 4: 119–123
   PubMed Web of Science ®Google Scholar
• Chiavetto LB, Boin F, Zanardini R, Popoli M, Michelato A, Bignotti S, et al. Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia. Biol Psychiatry 2002; 51: 480–484
   PubMedGoogle Scholar
• Gurling, H, Kalsi, G, Brynjolfson, J, Sigmundsson, T, Sherrington, R, Mankoo, BS, , et al. 2001. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21–22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3–24 and 20q12.1–11.23. Am J Hum Genet, 68:661–673.
   PubMed Web of Science ®Google Scholar
• He G, Zhang J, Li XW, Chen WY, Pan YX, Yang FP, et al. Interleukin-10–1082 promoter polymorphism is associated with schizophrenia in a Han Chinese sib-pair study. Neurosci Lett 2006; 394: 1–4
   PubMedGoogle Scholar
• Jun TY, Pae CU, Kim KS, Han H, Serretti A. Interleukin-10 gene promoter polymorphism is not associated with schizophrenia in the Korean populatio. Psychiatr Clin Neurosci 2003; 57: 153–159
   PubMedGoogle Scholar
• Kim YK, Myint AM, Lee BH, Han CS, Lee HJ, Kim DJ, et al. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 1129–1134
   PubMed Web of Science ®Google Scholar
• Kowalski J, Blada P, Kucia K, Lawniczex T, Madej A, Belowski D, et al. In-vitro immunomodulatory effects of haloperidol and perazine in schizophrenia. World J Biol Psychiatry 2000; 1: 190–196
   PubMedGoogle Scholar
• Kronfol Z, Remick DG. Cytokines and the brain: Implicationsfor clinical psychiatry. Am J Psychiatry 2000; 157: 683–694
   PubMed Web of Science ®Google Scholar
• Lazarus R, Klimecki WT, Palmer LJ, Kwiatkowski DJ, Silverman EK, Brown A, et al. Single-nucleotide polymorphisms in the interleukin-10 gene: differences in frequencies, linkage disequilibrium patterns, and haplotypes in three United States ethnic groups. Genomics 2002; 80: 223–228
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated acid. Nucleic Acids Res 1988; 16: 1215
   PubMed Web of Science ®Google Scholar
• Müller N, Riedel M, Ackenheil M, Schwarz MJ. Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J Biol Psychiatry 2000; 1: 173–179
   PubMedGoogle Scholar
• Ozbey U, Tug E, Kara M, Namli M. The value of interleukin-12B (p40) gene promoter polymorphism in patients with schizophrenia in a region of East Turkey. Psychiatry Clin Neurosci 2008; 62: 307–312
   PubMedGoogle Scholar
• Potvin S, Stip E, Spehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review. Biol Psychiatry 2008; 63: 801–808
   PubMed Web of Science ®Google Scholar
• Roh JW, Kim MH, Seo SS, Kim SH, Kim JW, Park NH, et al. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett 2002; 184: 57–63
   PubMedGoogle Scholar
• Rood MJ, Keijsers V, Linden MW, Tong TQ, Borggreve SE, Verweij CL. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis 1999; 58: 85–89
   PubMedGoogle Scholar
• Schosser A, Aschauer HN, Wildenauer DB, Schwab SG, Albus M, Maier W, et al. Homozygosity of the interleukin-10 receptor 1 G330R allele is associated with schizophrenia. Am J Med Genet 2007; 144B: 347–350
   PubMedGoogle Scholar
• Shirts BH, Wood J, Yolken RH, Nimgaonkar VL. Association study of IL10, IL1β, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: Suggestive association with rs16944 at IL1β. Schizophr Res 2006; 88: 235–244
   PubMed Web of Science ®Google Scholar
• Yu L, Yang MS, Zhao J, Shi YY, Zhao XZ, Yang JD, et al. An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population. Schizophr Res 2004; 71: 179–183
   PubMed Web of Science ®Google Scholar
• Zhang XY, Zhou DF, Zhang PY, Wu GY, Cao LY, Shen YC. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: Association with psychopathology. Schizophr Res 2002; 57: 247–258
   PubMed Web of Science ®Google Scholar